Since low RKIP expression in primary tumors was also a strong positive predictive factor for breast cancer recurrences [17, 30], we examined the prognostic value of different MMP13/RKIP expression combinations in breast cancers in which the expression of MMP13, RKIP and clinical outcome are available in published microarray expression data set. This evidence concerns the gene PEBP1 and breast cancer.